Mandideep Unit gets 483 letter from US FDA
Lupin Ltd stock was lower by 11% at Rs. 1329.
Mandideep Unit has received 483 letter from US FDA, as per a report.
Mandideep Unit has received 483 letter from US FDA, as per a report.
Report says that the active pharmaceutical ingredient (API) and formulations units of the plant in Madhya Pradesh have received two observations each.
The scrip opened at Rs. 1476.2 and has touched a high and low of Rs. 1494 and Rs. 1294.05 respectively. So far 9342947(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 67371.17 crore.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2127 on 06-Oct-2015 and a 52 week low of Rs. 1490 on 28-Mar-2016. Last one week high and low of the scrip stood at Rs. 1564.4 and Rs. 1490 respectively.
The promoters holding in the company stood at 46.53 % while Institutions and Non-Institutions held 43.56 % and 9.92 % respectively.
The stock is currently trading above its 200 DMA.